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Abstract: Ageing populations with multiple chronic conditions challenge low-, middle-,
and high-income countries. Older adults frequently depend on complex medication regimens
and polypharmacy, both of which can lead to potentially devastating and debilitating
medication-related problems and to subsequent far-reaching public health, social, and eco-
nomic effects. This perspectives article provides an overview of the current state of medica-
tion management, reﬂects on its relevance among polymedicated home-dwelling older adults
living with multiple chronic conditions, and proposes patient-centered approaches for opti-
mizing medication management and preventing medication-related problems.
Keywords: multiple chronic conditions, medication-related problems, caregivers,
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Ageing Populations with Multiple Chronic
Conditions Challenge Low-, Middle-, and
High-Income Countries
Ageing populations represent one of the most signiﬁcant current challenges to the long-
term sustainability and efﬁciency of the world’s healthcare and social services
systems.1 Despite increases in life expectancy, older adults are not experiencing better
health than previous generations.2 Worldwide, the prevalence of multimorbidity in
older adults ranges from 55–98%3 In Switzerland, 25.2% of adults aged from 65–79
years old, and 41.3% of those aged 80 or more, live at home with multimorbidity.4
Three major operational deﬁnitions of multimorbidity co-exist in the literature: co-
occurrence of at least two diseases in the same individual; cumulative indices con-
sidering both the number and severity of concurrent diseases; and the simultaneous
presence of not only diseases but also their associated symptoms and physical and
cognitive dysfunctions.3 To properly cover the heterogeneity and complexity of older
adults’ health statuses, this paper uses the term multiple chronic conditions to encom-
pass all three deﬁnitions.5 Older adults living with multiple chronic conditions present
a poorer quality of life, declines in functional ability and mobility,3 and shorter life
expectancy, particularly those with cognitive impairment and/or cardiovascular
disease.6 The concept of multiple chronic conditions is also associated with increased
psychological distress and repeated and prolonged hospitalizations.3 Although the
expanding number of patients with multiple chronic conditions is considered a public
health concern, prevalence often remains unclear, especially given the absence of any
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consensual deﬁnition in ongoing epidemiological investiga-
tions. Nonetheless, regardless of the deﬁnition, multiple
chronic health conditions among home-dwelling older adults
have been strongly associated with polypharmacy and med-
ication-related problems (MRPs) in multiple observational
and epidemiological studies.7,8
Polypharmacy and
Medication-Related Problems
Older people with multiple chronic conditions—particu-
larly those with cognitive impairment and/or psychiatric
disorders—frequently depend on complex medication
regimens. A recent Swiss study reported that more than
80% of home-dwelling older adults took at least one drug
daily, with some taking up to 17.9 Indeed, 27% had a daily
intake of ﬁve or more drugs, with numbers increasing with
age: 18% of those aged 69–74, rising to 38% of those aged
85 or more. However, nearly 50% of older adults took at
least one medication that was not medically required.9
Although the use of multiple medicines or polyphar-
macy may be clinically appropriate in many cases, it is
imperative to identify those older adults with inappropriate
polypharmacy prescriptions that may put them at a greater
risk of MRPs and adverse health outcomes.10,11 To distin-
guish between appropriate and inappropriate polyphar-
macy, Masnoon et al (2017) conducted a systematic
literature review to explore the different deﬁnitions of
polypharmacy.12 They found 138 deﬁnitions of polyphar-
macy and associated terms. Although the most commonly
used deﬁnition of polypharmacy is taking ﬁve or more
medicines,12 the variety of deﬁnitions could confuse clin-
icians in practice and make it difﬁcult to assess the safety
and appropriateness of a medication therapy in clinical
settings. There is an urgent need for an international con-
sensus deﬁnition of polypharmacy, including how to assess
inappropriate polypharmacy, in order to optimize medica-
tion management and clinical follow-up and to enable
precisely comparable criteria in research.
Regardless of polypharmacy’s deﬁnition, polymedicated
older adults are more susceptible to MRPs, including adverse
drug reactions, medication errors, and non-adherence,
which often result in emergency department visits and
hospitalizations.10,11 Up to 25% of emergency department
visits by home-dwelling older adults with multiple chronic
conditions are attributable to an MRP.13 Nonetheless, 60% of
MRPs in older patients visiting emergency departments with
non-speciﬁc signs and symptoms (such as weakness) may go
undiagnosed as such, whereas 83% of those MRPs may be
accountable for acute morbidity.13MRPs also frequently result
in readmission: in one study following older patients for six
months after hospital discharge, they were the most frequent
cause.14 Evidence suggests that the risk of an MRP increases
not only with age and the number of comorbidities but also
with the number of medications prescribed and with certain
classes of drugs, such as medicines for cardiovascular diseases
and diabetes.11,13 Thus, MRPs can lead to a degradation in the
patient’s clinical condition, physical and cognitive decline, an
exacerbation of chronic medical conditions, and avoidable
health costs.13,15 MRPs can be devastating and debilitating
for older people, and they can have far-reaching public health,
social, and economic impacts.
A possible explanation for high numbers of MRPs is that
most clinical guidelines and intervention care models were
designed using short-term randomized controlled trials invol-
ving single health conditions. This contrasts with the current
reality of the multiple, chronic, and often interacting health
conditions affecting older people. Trying to implementmulti-
ple clinical guidelines for a single disease among older adults
with multiple chronic conditions may result in contradictory
and potentially harmful recommendations.16 The pathophy-
siological processes, clinical features, and interactions of
age-related conditions must be disentangled, as much as
possible, in order to personalize medication and its manage-
ment and to realign older adults, caregivers, and healthcare
systems so as to prevent MRPs.
Due to the high prevalence of polypharmacy and
MRPs, together with their impact on older adults’ quality
of life and public healthcare expenditure, medication man-
agement has emerged as a priority in clinical settings. Its
necessity among older adults has also become the focus of
considerable research interest and media attention over the
last decade (Figure 1). However, the mechanisms behind
poor medication management are not well deﬁned.
The present paper provides a timely addition to the bur-
geoning body of evidence offering new perspectives on our
understanding of medication management—well beyond the
act of medical prescription itself—among polymedicated
home-dwelling older adults with multiple chronic conditions.
Optimizing Medication Use Among
Older Adults with Multiple Chronic
Conditions
MRPs are a reﬂection of the complexity of dealing with
polypharmacy and age-related multiple chronic conditions;
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they are causally underpinned by interacting and often
unclear pathophysiological, pharmacodynamic, and phar-
macokinetic processes. Furthermore, the signs of a normal
ageing process are not always easy to tell apart from the
potential pathophysiological deviations induced by under-
lying chronic conditions.17,18 The occurrence of MRPs is
strongly affected by a broad range of factors and determi-
nants, which are not conﬁned to single biological systems
or human health domains.17 Environmental and social
factors also substantially inﬂuence MRPs.11
MRPs are nonetheless preventable with appropriate,
well-coordinated primary care.11,13,19 For example,
20–30% of avoidable older adult readmissions have been
directly related to non-adherence.20 Some of the current
evidence-based strategies for medication safety and the
prevention of MRPs include medication reconciliation,
systematic review of prescribed medications, deprescrib-
ing, and electronic medication management systems.21,22
Medication reconciliation is a well-documented good
practice corresponding to the process of creating and updat-
ing a single list of an older adult’s medication;23 this ensures
a systematic, comprehensive review of all the patient’s cur-
rent medicines. Prior research has shown that discharge
letters received by primary care professionals are frequently
inaccurate and lack key information.24 Regular medication
reconciliation reduces medication errors by consistent com-
munication across transitions of care, including changes in
the clinical setting, medical practitioner, or level of care.25
Regularly and systematically reviewing prescribed
medications is a straightforward, effective means of redu-
cing inappropriate prescribing and, therefore, a preventive
strategy for avoiding MRPs. Inappropriate prescribing
includes potentially inappropriate medications and poten-
tial prescribing omissions. Existing screening tools—such
as the STOPP/START criteria (Screening Tool of Older
Persons’ Prescriptions/Screening Tool to Alert to Right
Treatment) —recognize the dual nature of inappropriate
prescribing by including a list of potentially inappropriate
medications (STOPP criteria) and potential prescribing
omissions (START criteria).26 Complementary to this, the
American Geriatrics Society Beers Criteria is a list of
potentially inappropriate medications that it is preferable
for older adults to avoid in most situations or particular
health conditions.27
Deprescribing attempts to balance the potential beneﬁts
and harms of tapering or ceasing inappropriate medication
with the aim of managing polypharmacy and improving
outcomes.28 Deprescribing is particularly relevant among
frail older adults with multiple chronic conditions, as they
face high risks of MRPs, hospitalization, and early death.21
Electronic medication management systems are recent
digital developments covering prescriptions, administra-
tion, pharmacy reviews, medication administration using
barcodes, and all the electronic devices devoted to medi-
cation management processes.22 Electronic medication
management systems contribute to reducing medication
errors and enhancing interprofessional collaboration and
patient safety by using red ﬂag strategies.29,30 In recent
years, smartphone applications for optimizing medication
use have also emerged. However, older adults, who can
experience the greatest beneﬁts from more electronic sup-
port to improve their medication use, are also the least
accustomed to using them.21
Integrating Older Adults’ Preferences
into Medication Management
Preventability and an understanding of risk factors are
crucial to co-constructing interventions to minimize
MRPs.11,19 However, research about MRPs and medica-
tion management currently focuses on healthcare profes-
sionals’ perspectives, to which the perspectives and
experiences of patients and informal caregivers are often
secondary. Research into medication management has
evolved with little consideration of the perspectives and
preferences of older adults themselves. Further studies—
Figure 1 Papers referenced in Pubmed over the last 20 years on medication
management among older adults.
Notes: Graph obtained with the following research equation: (“Aged”[Mesh] OR
“Geriatrics”[Mesh] OR “Geriatric Psychiatry”[Mesh] OR “Geriatric Nursing”[Mesh]
OR “Geriatric Assessment”[Mesh] OR “Health Services for the Aged”[Mesh]) AND
(“Medication Therapy Management”[Mesh] OR “Drug Monitoring”[Mesh] OR “Product
Surveillance, Postmarketing”[Mesh] OR “Drug Utilization Review”[Mesh] OR
“Deprescriptions”[Mesh] OR “Potentially Inappropriate Medication List”[Mesh] OR
“Medication Reconciliation”[Mesh] OR “Medication Systems”[Mesh] OR “Medication
Errors/prevention and control”[Mesh] OR “Prescription Drug Overuse/prevention and
control”[Mesh] OR ((“Drug Therapy”[Mesh] OR “Drug Prescriptions”[Mesh]) AND
(“Self-Care”[Mesh] OR “Patient Education as Topic”[Mesh]))) AND (“1998/01/
01”[PDAT]: “2018/12/31”[PDAT]).
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using qualitative or mixed research designs—will be
essential to identify the logic which home-dwelling older
adults with multiple chronic conditions apply to the man-
agement of their daily medication and how they integrate
it into the rhythm of their daily lives and home
environments.14,19 Shared decision-making must be pro-
moted, notably via operational tools providing information
on the beneﬁts and risks of medicines in a format which
older adults can embrace more easily.31 Even though
empowering patients to participate in their medication
management has beneﬁcial effects—particularly in medi-
cation adherence32—the concept of older adult empower-
ment and self-management of complex medication
regimens, along with their impact on MRPs, has been
poorly investigated. Quasi-experimental studies and ran-
domized controlled trials will be essential for any adequate
exploration of the effectiveness of innovative interventions
aiming to empower older adults’ medication management,
improve their competences, and enhance shared decision-
making with healthcare professionals.
The Roles and Accountability of
Healthcare Professionals
The complexity of care required by home-dwelling older
adults with multiple chronic conditions leads them to be
signiﬁcant users of healthcare services and to consult many
different healthcare professionals.33 Medication manage-
ment among this population consequently requires interpro-
fessional collaboration across different healthcare and social
services providers and organizations.16 Besides prescribers,
usually general practitioners and different specialist physi-
cians, pharmacists, nurses, and other allied health profes-
sionals may be involved in and accountable for medication
management.16 In Australia, collaborative home medicines
reviews (involving a general practitioner and a pharmacist)
have demonstrated their effectiveness in detecting, prevent-
ing, and resolving MRPs among home-dwelling older adults
with multiple chronic conditions.16 Furthermore, adherence
to prescribed medication can also be improved by pharma-
cist- and nurse-led interventions.34–37 However, the higher
the number of healthcare professionals consulted by home-
dwelling older adults with multiple chronic conditions, the
greater the chance that care may be fragmented and
uncoordinated.16 This can be explained by the different treat-
ment preferences of different healthcare professionals.
Home-dwelling older adults with multiple chronic conditions
often fail to receive the efﬁcient, effective, and coordinated
care that they could gain so much from.38,39 Failure to
coordinate care for home-dwelling older adults with multiple
chronic conditions undeniably increases the risk of MRPs.16
Those who consult three or more healthcare professionals
report receiving conﬂicting advice, which makes it difﬁcult
for them to know which guidance they should follow.
Inadequate explanations about medication result in omis-
sions and incorrect dosages, but also in anxiety and confusion
in older adults.40 Healthcare professionals should feel
accountable for optimizing medication management among
home-dwelling older adults, particularly during their transi-
tions home from acute care settings. Implementing effective
primary care management should be a priority among home-
dwelling older adults with multiple chronic conditions in
order to prevent adverse health outcomes and to promote
autonomy in their daily lives. Older adults at a high risk of
MRPs should systematically be assigned a primary care
manager whose aim is to meet their needs with regards to
prevention and chronic conditions. By using planned inter-
actions and ensuring appropriate follow-up, primary care
managers can contribute signiﬁcantly to the prevention of
hospital admissions, rehospitalizations, institutionalization in
nursing homes, and early death.41,42
The Role of Informal Caregivers
In addition to healthcare professionals’ contributions to
medication management, informal caregivers help to
ensure safe, appropriate medication use at home by older
adults with multiple chronic conditions, notably among
those who may also have cognitive impairment.43–,45
Although the role of informal caregivers in medication
management is very relevant, various constraints have
been reported regarding the time required, anxiety about
making mistakes, and the uncollaborative behavior of
older adults.46 They also face difﬁculties maintaining con-
tinuous supplies of medicines, supporting administrative
work, making clinical decisions, and handling conﬂicts or
disagreements with the older adult,46 or even with health-
care professionals in regards to ineffective medicinal
practices.43,46 Although several studies have furthered
understanding about the daily challenges faced by infor-
mal caregivers managing medication for older adults, there
has been less insight into any educational or training
interventions aimed at improving caregivers’ medication
management competences. More studies are required to
explore how to efﬁciently support informal caregivers in
their roles as medication managers. Psychoeducation, digi-
tal applications, or specialized counselling services
Pereira et al Dovepress
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provided by pharmacists or advanced practice nurses
should also be considered.44,45,47 Cooperating with infor-
mal caregivers and integrating their experiences of shared
decision-making should be one of the tasks assigned to
primary healthcare professionals. To make this a reality,
they could receive backing from their hierarchies and
perhaps even ﬁnancial incentives to support informal care-
givers in the optimization of medication management.
More research will be needed to analyze the effectiveness
of such incentives.
Ways to Bridge the Gap
Optimal medication management is one of the basic precondi-
tions for home-dwelling older adults with multiple chronic
conditions to be able to remain at home and preserve their
quality of life.7,48 Improving medication management for
them not only requires regular monitoring of MRPs and
reviewing of prescriptions to eliminate unnecessary medica-
tion but also coordinated care by different healthcare and
social services providers.49 This calls for an integrated, multi-
stakeholder model to optimize medication management
among home-dwelling older adults with multiple chronic con-
ditions. Such a medication management model should be
rigorously structured using a care model process embracing
development, implementation, and sustainability milestones.50
It should also consider the quadruple aim of enhancing the
patient’s experience, improving population health, reducing
costs, and improving healthcare professionals’ working
lives.51 Indeed, both these frameworks underpin the ongoing
mixed-methods research by Pereira et al, which brings
together retrospective and prospective ﬁndings to promote
medication management and prevent MRPs.52 Such a model
should be able to more adequately capture the biological,
clinical, psychosocial, and pharmacological complexities of
multiple chronic conditions and polypharmacy. A robust, inte-
grated, multi-stakeholder model that embeds care in the con-
text of where and how older adults with multiple chronic
conditions live needs to be developed to prevent the onset
and/or progression of MRPs.
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